US OptionsDetailed Quotes

TELA241220P2500

Watchlist
  • 0.05
  • 0.000.00%
15min DelayTrading Nov 18 12:48 ET
0.00High0.00Low
Intraday
  • 5D
  • Daily

News

Comments

    Jaguar8
    Jaguar8
    Oct 23 07:10
    NEWS
    $TELA Bio (TELA.US)$
    TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
    TELA Bio has announced the pricing of a public offering comprising 12,000,000 shares of common stock at $2.25 per share and pre-funded warrants for 5,800,000 shares at $2.2499 per warrant. The offering is expected to generate $40 million in gross proceeds before expenses. The company has granted underwriters a 30-day option to purchase up to 2,670,000 additional shares. The offering, exp...
    Jaguar8
    Jaguar8
    Apr 15 06:05
    $TELA Bio (TELA.US)$
    NEWS
    TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
    TELA Bio, Inc. announces the U.S. commercial launch of OviTex IHR, a reinforced tissue matrix for inguinal hernia repair. The product offers trocar-compatibility for laparoscopic and robotic procedures, with three configurations available. OviTex has a strong clinical track record with low recurrence rates and high pati...
    stockhub
    stockhub
    Mar 22 07:42
    TELA
    $TELA Bio (TELA.US)$
    Beat revenue estimates and near miss on GAAP.
    FDA approved surgical device
    Buy this asap
    Moomoo AI
    Moomoo AI
    Oct 9, 2023 19:45
    Despite TELA Bio's high revenue growth, its P/S ratio barely aligns with industry median, indicating public skepticism about future growth. Its current stock price could be attractive, yet it shows two risk signs.
    Market Cool On TELA Bio, Inc.'s (NASDAQ:TELA) Revenues Pushing Shares 25% Lower
Read more